The most common genetic mutations identified in small-cell lung cancer (SCLC) patients are in the genes MYC, BCL2, and p53, whereas mutations in genes such as EGFR, KRAS, and p16 are known to be associated with non-small-cell lung cancer (NSCLC) [3,4,5]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.